CCK-8 vs MTS vs ATP Assays in 3D Models: Choosing the Right Viability Readout
A practical comparison of WST-8/CCK-8, MTS and ATP-based measurements for spheroids, organoids, hydrogels and other three-dimensional cell culture models.
Quick answer
There is no universally best viability assay for every 3D model. CCK-8/WST-8 is often a practical starting point when a simple absorbance workflow and soluble formazan product are preferred. MTS is established and convenient, but its response can be more dependent on spheroid size, incubation and diffusion. ATP-based measurement is frequently the strongest endpoint for dense or larger 3D structures when high sensitivity is required, provided that complete spheroid disruption, ATP extraction and matrix compatibility are validated. For publication-grade or decision-critical studies, combine the metabolic readout with an orthogonal method such as imaging, live/dead staining, membrane-integrity analysis or histology.
Why cell viability testing is more difficult in 3D models
Conventional monolayer cultures expose most cells directly to the surrounding medium. Spheroids and organoids create a more complex architecture in which cells are arranged at different depths, experience different oxygen and nutrient levels, and may be surrounded by extracellular matrix or a hydrogel.
These features are biologically valuable because 3D models can reproduce gradients, cell–cell interactions and tissue-like organization that are not present in a flat monolayer. They also create analytical barriers that can change how quickly an assay reagent enters the structure and how efficiently the resulting signal leaves it.
The 3D assay problem is a transport problem
A low signal can indicate fewer viable cells, but it can also result from incomplete reagent penetration, slow diffusion, insufficient incubation, inefficient lysis, matrix interference or signal saturation. The assay must therefore be validated against the dimensions and composition of the model, not only against the number of cells originally seeded.
Organoid research is expanding rapidly in disease modelling, drug screening and precision medicine. University organoid cores, including those at the University of Pittsburgh and KU Leuven, describe 3D models as tools for studying human tissues and testing therapeutic responses. The US Food and Drug Administration is also promoting validated new approach methodologies, including advanced human-relevant in vitro systems, as part of its strategy to reduce reliance on animal testing.
What do CCK-8, MTS and ATP assays actually measure?
The word viability is often used as though it were a direct count of living cells. In practice, these assays measure biological activity associated with viable cells. The relationship between signal and living cell number must be established experimentally.
- CCK-8/WST-8 and MTS measure the conversion of tetrazolium reagents into colored formazan products by metabolically active cells.
- ATP assays measure intracellular ATP or an ATP-dependent signal after sample processing, extraction or lysis.
- None of these methods independently reveals where live and dead cells are located inside a spheroid or whether a viable rim surrounds a necrotic core.
CCK-8/WST-8 assays in spheroids and organoids
CCK-8 assays use WST-8, a water-soluble tetrazolium salt. Cellular dehydrogenase activity reduces WST-8 to a soluble orange formazan product. Because the product remains soluble, the workflow is generally simpler than older assays that require dissolution of an insoluble crystal.
The AffiASSAY® Cell Counting Kit 8 (WST-8 / CCK-8) is designed for colorimetric measurement of cell viability and proliferation, with absorbance measurement at 450 nm. AffiGEN also offers the AffiCELL® CCK-8 Cell Counting Kit as another ready-to-use WST-8 format.
Potential advantages in 3D culture
- Simple absorbance-based plate-reader workflow
- Soluble formazan product without a crystal-dissolution step
- Useful for dose-response screening when a validated linear range is established
- Can be less disruptive than a fully lytic endpoint assay
- Convenient for laboratories using standard absorbance readers
Important limitations in 3D culture
- Reagent penetration can vary with spheroid diameter and compactness
- Long incubation can alter the response or exceed the linear signal range
- Hydrogels, media components and test compounds may affect absorbance
- Metabolic state can change independently of cell number
- Repeated use on the same model should not be assumed to be non-perturbing without validation
CCK-8 is often a strong first option for small-to-medium spheroids when absorbance detection is preferred. However, a standard curve should be created using the actual 3D format because a calibration produced with dissociated monolayer cells may not represent reagent access inside intact spheroids.
MTS assays in spheroids and organoids
MTS is another tetrazolium-based method. Metabolically active cells reduce MTS to a soluble formazan product that can be quantified by absorbance. This makes the assay convenient for routine proliferation and cytotoxicity studies.
The AffiASSAY® MTS Cell Proliferation Colorimetric Assay Kit is designed for colorimetric evaluation of cell proliferation and viability in research workflows.
Potential advantages in 3D culture
- Familiar and straightforward colorimetric workflow
- Soluble signal product compatible with plate-reader measurement
- Useful when an established laboratory protocol has already been validated
- Suitable for comparative treatment groups within a controlled model
Important limitations in 3D culture
- Signal may correlate with spheroid size only across a limited range
- Incubation time can strongly influence sensitivity and background
- Dense aggregates may limit reagent access to internal cells
- Long reagent exposure may affect cells in some experimental systems
- Performance cannot be transferred automatically from 2D to 3D culture
MTS remains usable when the model has already been characterized with suitable controls. For a new 3D workflow, WST-8/CCK-8 may provide a more practical tetrazolium starting point, but the final choice should be determined by model-specific data rather than by assay popularity.
ATP-based measurements in spheroids and organoids
ATP declines rapidly when cells lose metabolic integrity, making intracellular ATP a useful endpoint for many viability and cytotoxicity studies. In 3D cultures, the central technical challenge is not only detection sensitivity but also complete disruption of the structure and recovery of ATP from cells at every depth.
The AffiASSAY® ATP Colorimetric & Fluorometric Assay Kit quantifies ATP in prepared biological samples using either absorbance at OD 570 nm or fluorescence at Ex/Em 535/587 nm. It is a prepared-sample ATP quantification workflow rather than a direct-add luminescent 3D viability reagent. Researchers adapting it to spheroids or organoids must establish an appropriate disruption, extraction and recovery procedure before interpreting ATP as a viability endpoint.
Potential advantages in 3D culture
- High analytical sensitivity when extraction and detection are optimized
- Useful for dense, large or matrix-embedded cultures after complete disruption
- Can provide a broad quantitative range with suitable standards
- Well suited to endpoint drug-screening workflows
- Compatible with normalization to protein, DNA, spheroid number or model volume
Important limitations in 3D culture
- The measurement is destructive and normally prevents continued culture
- Incomplete lysis or extraction can underestimate internal viable cells
- ATP per cell changes with stress, differentiation and metabolic state
- ATP is unstable, so sample handling and temperature control are critical
- Matrix components or tested compounds may interfere with the detection chemistry
The NIH-hosted Assay Guidance Manual emphasizes that compact 3D structures and extracellular matrix create barriers to reagent access and lysis. It recommends empirically determining the disruption and lysis conditions for each 3D format.
CCK-8 vs MTS vs ATP: practical comparison for 3D models
| Feature | CCK-8 / WST-8 | MTS | ATP measurement |
|---|---|---|---|
| Primary biological signal | Tetrazolium reduction associated with metabolic activity | Tetrazolium reduction associated with metabolic activity | Amount of intracellular ATP recovered from the sample |
| Typical detection | Absorbance; AffiASSAY CCK-8 is read at 450 nm | Absorbance at the wavelength specified by the kit protocol | Absorbance, fluorescence or luminescence depending on assay chemistry |
| Destructive? | Not inherently lytic, but repeated exposure must be validated | Not inherently lytic, but long exposure may perturb some cells | Usually destructive because extraction or lysis is required |
| 3D penetration concern | Moderate to high as spheroid size and compactness increase | Moderate to high; response may be strongly incubation-dependent | Replaced by the need for complete physical and chemical disruption |
| Best starting use case | Small-to-medium spheroids with an absorbance workflow | Established laboratory protocol with model-specific calibration | Dense or larger endpoint models requiring high sensitivity |
| Main risk | Under-reading internal cells or signal saturation | Limited specificity or inconsistent response across spheroid sizes | Incomplete ATP recovery or interpreting metabolic change as cell death |
| Recommended confirmation | Brightfield growth, live/dead staining or membrane-integrity endpoint | Imaging plus an independent viability or cytotoxicity assay | Imaging, DNA/protein normalization and evidence of complete disruption |
Laboratories choosing between absorbance and fluorescence detection can also review the AffiGEN guide Colorimetric vs Fluorometric Assay Kits: Which Detection Method Should You Use?
What did the direct CCK-8, MTS and ATP comparison find?
A 2024 comparative study evaluated MTS, WST-8 and an ATP endpoint in primary human chondrocytes grown as both 2D monolayers and 3D spheroids. The study is useful because the same biological system was tested with three methodologically different readouts.
Key findings from the chondrocyte model
- All three assays correlated with seeded cell number in 2D culture.
- MTS showed the lowest specificity in the tested system.
- WST-8 and MTS correlated with only certain spheroid-size ranges.
- ATP correlated across spheroids ranging from approximately 100 to 1000 µm.
- WST-8 showed the second-best sensitivity and detected larger spheroids in that model.
- The authors preferred WST-8 over MTS among the tetrazolium methods.
These results do not establish a universal diameter threshold for every cell type. Chondrocyte spheroids have their own metabolism, compactness and extracellular matrix. The transferable conclusion is that assay performance changes with 3D architecture and must be demonstrated across the complete size range used in the experiment.
The full study is available through PubMed Central and the journal publication page.
Which assay should you choose for your 3D model?
You need a simple absorbance screen
Start with CCK-8 when spheroids are relatively small or moderately compact, a standard absorbance reader is available, and you can validate signal linearity across the full size and treatment range.
Your model already has a validated legacy method
Continue with MTS when historical data, acceptance criteria and model-specific calibration are already established. Revalidate when changing cell type, plate, matrix, spheroid diameter or incubation time.
You need a sensitive destructive endpoint
Use ATP when dense or larger models require a sensitive endpoint and the protocol can demonstrate complete spheroid disruption, efficient recovery and a signal within the assay’s validated dynamic range.
How to validate CCK-8, MTS or ATP for a 3D culture
A short validation experiment can prevent large drug-screening studies from producing an apparently precise but biologically misleading result.
Define the 3D model range
Record cell type, matrix, plate format, culture age, spheroid count, diameter and expected response to treatment.
Create a model-specific calibration series
Test multiple known cell inputs or spheroid sizes using the same culture format, matrix volume and plate type planned for the final experiment.
Optimize incubation or extraction
For CCK-8 and MTS, compare several incubation times. For ATP, compare disruption and extraction conditions and verify that no intact core remains.
Test matrix and compound interference
Include cell-free matrix controls, reagent blanks, vehicle controls and compound-only wells when test substances may absorb, fluoresce or react.
Confirm the useful dynamic range
Identify the range in which the signal changes predictably without saturation, excessive background or loss of proportionality.
Add an orthogonal endpoint
Compare metabolic signal with spheroid area, live/dead imaging, DNA, protein, LDH release, histology or another independent measurement.
Suggested minimum plate controls
| Control | Purpose | CCK-8 / MTS | ATP |
|---|---|---|---|
| Reagent blank | Measures assay-reagent background | Medium plus reagent | Extraction buffer or assay buffer plus reaction mix |
| Cell-free matrix | Detects scaffold or hydrogel interference | Matrix plus medium and reagent | Matrix processed through the same extraction procedure |
| Vehicle control | Defines the untreated reference response | Essential | Essential |
| Positive death control | Confirms that the assay detects a strong viability decrease | Use a validated cytotoxic condition | Use a validated cytotoxic condition and confirm ATP recovery |
| Compound-only control | Detects optical or chemical interference | Important for colored or redox-active compounds | Important for fluorescent, colored or enzyme-interfering compounds |
| Size or cell-input series | Defines proportionality and dynamic range | Required for each major 3D format | Required for each extraction and detection mode |
Common reasons 3D viability results become misleading
1. Spheroids are not uniform before treatment
Variation in starting diameter can be larger than the treatment effect. Record brightfield images before dosing and define acceptable size or circularity limits.
2. Incubation time was copied directly from a 2D protocol
A short incubation may not reach the spheroid core, while a long incubation may saturate the signal or change cell physiology. Test a time course using the actual 3D model.
3. The matrix contributes background or slows diffusion
Basement-membrane extracts, collagen, synthetic hydrogels and scaffold materials can behave differently. Include a cell-free matrix control and keep matrix volume consistent across wells.
4. A test compound interferes with the detection chemistry
Colored compounds can affect absorbance; fluorescent compounds can increase background or quench signal; redox-active compounds can influence tetrazolium conversion; enzyme inhibitors may affect ATP detection chemistry.
5. ATP extraction is incomplete
A visibly dispersed spheroid is not always fully lysed. Confirm disruption by microscopy, compare mixing or extraction times and test whether a second extraction recovers additional ATP.
6. Metabolic suppression is reported as cell death
Cytostatic drugs, differentiation, hypoxia and nutrient limitation may reduce ATP or tetrazolium conversion while many cells remain viable. Pair the metabolic assay with an orthogonal cell-death or structural endpoint.
Explore AffiASSAY® cell viability and metabolic assays
Compare WST-8/CCK-8, MTS and ATP measurement formats for your research workflow. Review the complete product information and validate compatibility with your cell type, matrix, plate format and three-dimensional model.
Frequently asked questions about CCK-8, MTS and ATP in 3D culture
Is CCK-8 suitable for 3D spheroids?
CCK-8 can be used with many spheroid models, but suitability must be demonstrated for the specific cell type, spheroid diameter, compactness, matrix and incubation time. A model-specific calibration curve is strongly recommended.
Is CCK-8 better than MTS for 3D cell viability?
WST-8/CCK-8 may offer better sensitivity and lower perturbation than MTS in some models. A 2024 chondrocyte study preferred WST-8 among the tested tetrazolium methods, but the result should not be treated as universal for every organoid or spheroid.
Why can CCK-8 and MTS underestimate large spheroids?
Large or compact spheroids can limit reagent diffusion and slow the release of the soluble signal product. The viable core may therefore contribute less signal than cells near the surface.
Is ATP always the best assay for organoids?
No. ATP can be sensitive and useful for dense 3D models, but it is normally destructive and requires complete extraction or lysis. ATP levels can also change because of metabolic adaptation without an equivalent change in cell number.
Can the AffiASSAY ATP kit be added directly to intact spheroids?
The AffiASSAY ATP Colorimetric & Fluorometric Assay Kit is designed for ATP quantification in prepared biological samples. An intact-spheroid workflow would require validated disruption and sample-preparation steps; direct addition should not be assumed.
Can I measure the same spheroid repeatedly with CCK-8?
Possibly, but repeated measurement must be validated. Reagent exposure, incubation, washing and changes in culture volume may affect subsequent growth or metabolic activity.
What is the best assay for very large spheroids?
A validated ATP endpoint is often a strong candidate for large or dense spheroids because the structure can be disrupted before measurement. Complete lysis, ATP recovery and dynamic range must still be demonstrated.
Should viability be normalized to spheroid size?
Normalization may be useful, but it depends on the question. Spheroid area, volume, DNA, protein, starting cell number and spheroid count provide different biological interpretations. The selected denominator should be predefined and applied consistently.
What orthogonal assay should be used with CCK-8 or ATP?
Suitable options include brightfield size analysis, live/dead fluorescence, membrane-integrity assays, DNA or protein quantification, histology and high-content imaging. Select a method that measures a different biological property from the primary metabolic assay.
Authoritative resources and further reading
- PubMed Central: MTS, WST-8 and ATP Viability Assays in 2D and 3D Cultures
- NIH Assay Guidance Manual: ATP-Based Cell Viability and Toxicity Assays for 3D Spheroids
- US FDA: Roadmap to Reducing Animal Testing in Preclinical Safety Studies
- US FDA: New Approach Methodologies
- University of Pittsburgh: Organoid Research Core
- KU Leuven: Organoid and Complex 3D Model Research
- Princeton University: Organoid Development Shared Resource